Consumption of 4D Dietary Supplement on Perceptual-Cognitive and Visual-Motor Performance

Dietary Supplementation Clinical Trial

Official title:

Acute Consumption of 4D Dietary Supplement vs. Placebo: Effects on Perceptual-Cognitive and Visual-Motor Performance

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04988919
• Other study ID #: STUDY00003029
• Status: Completed
• Phase: N/A
• Start date: July 26, 2021
• Est. completion date: October 4, 2021

Study information

• Verified date: October 2021
• Source: University of Central Florida
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this investigation is to determine if supplementation with the 4D dietary supplement impacts perceptual-cognitive and visual-motor skills in healthy individuals.

Description:

Multi-ingredient supplements (MIS) have been reported to positively impact various aspects of performance. While caffeine alone has been shown to improve aerobic performance, resistance training (such as bench press), reaction time and sprint performance, it has also been suggested that it lacks the ability to improve cognition. Therefore, the purpose of this investigation is to examine the effects of a caffeine containing MIS on measures of cognition and reaction time, with the intent of providing additional benefits to athletic performance.

This study will utilize a randomized, double-blind, placebo-controlled design. Following two familiarization trials, participants will complete two testing visits. During these visits, they will complete baseline assessments, consume either the 4D dietary supplement or a taste matched placebo, and rest for 45 minutes. Reaction time, cognition assessments (visual tracking speed), and reactive agility performance will be assessed following the rest period.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 24
• Est. completion date: October 4, 2021
• Est. primary completion date: October 4, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• Male or female between the ages of 18-40 years old

• Determined to be healthy by the MHQ and PAR-Q+

Exclusion Criteria:

• Any response of "yes" on the PAR-Q+

• Daily caffeine consumption greater than 200 mg

Related Conditions & MeSH terms

• Dietary Supplementation

Intervention

Dietary Supplement:
• 4D
multi-ingredient supplement mixed with 24 ounces of water
• placebo
taste-matched placebo mixed with 24 ounces of water

Locations

Country	Name	City	State
United States	University of Central Florida	Orlando	Florida

Sponsors (2)

Lead Sponsor	Collaborator
University of Central Florida	4D, LLC

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in reactive agility time	Determined via Y-Reactive Agility test using the Witty Wireless Timing Gate system	post supplement ingestion on both testing days (Day 3 and Day 4)
Primary	Change in reaction time in response to supplement/placebo consumption	Determined via Dynavision D2, Mode A	pre and post supplement ingestion on both testing days (Day 3 and Day 4)
Primary	Change in visual tracking speed in response to supplement/placebo consumption	Determined via multiple object tracking test on the Neurotracker	pre and post supplement ingestion on both testing days (Day 3 and Day 4)